Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M492Revenue $M42.2Net Margin (%)21.3Z-Score2.4
Enterprise Value $M375EPS $0.8Operating Margin %20.4F-Score6
P/E(ttm))26.5Cash Flow Per Share $0Pre-tax Margin (%)19.0Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %0Quick Ratio3.3Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %0Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)11.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M20.6ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with HPTX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

HPTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

HPTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2014-07-02Sell200$28-14.71 view
SANDELL SCOTT D10% Owner 2014-06-06Sell1,430$5.54331.05 view
DRANT RYAN D10% Owner 2014-06-06Sell1,134$26.9-11.23 view
BARRETT M JAMES10% Owner 2014-06-06Sell1,430$26.88-11.16 view
BASKETT FOREST10% Owner 2014-06-06Sell1,377$26.9-11.23 view
BARRIS PETER J10% Owner 2014-06-06Sell1,134$26.9-11.23 view
KOLLURI KRISHNA KITTU10% Owner 2014-06-06Sell120$27.19-12.17 view
SOFINNOVA VENTURE PARTNERS VII10% Owner 2014-06-04Sell417,747$27.7-13.79 view
HEALY JAMESDirector 2014-06-04Sell417,747$27.7-13.79 view
Nash Christine ASVP & Chief Commercial Officer 2014-03-06Sell5,100$29.05-17.8 view

Press Releases about HPTX :

    Quarterly/Annual Reports about HPTX:

    News about HPTX:

    Articles On GuruFocus.com

    More From Other Websites
    Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 Oct 14 2014
    Hyperion, Clal Biotech resolve dispute over diabetes drug Oct 07 2014
    Hyperion Therapeutics and Clal Biotechnology Industries Ltd. Enter Into Interim Agreement Oct 07 2014
    Ardelyx (ARDX) Worth Watching: Stock Moves 16% Higher Oct 06 2014
    NanoViricides, Inc. (NNVC) in Focus: Stock Jumps 9.9% Oct 06 2014
    Esperion Therapeutics (ESPR) in Focus: Stock Jumps 5.1% Oct 06 2014
    Durata Therapeutics, Inc. (DRTX) Surges: Stock Rises 17.3% Oct 06 2014
    Alcobra (ADHD) Crumbles: Stock Falls by 7.4% Oct 06 2014
    Zogenix (ZGNX) Shows Strength: Stock Adds 11.2% in Session Oct 06 2014
    BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 12.4% Oct 06 2014
    Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher Sep 29 2014
    Cerulean Pharma (CERU) Jumps: Stock Up 9.8% in Session Sep 29 2014
    IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session Sep 26 2014
    Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% Sep 25 2014
    Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% Sep 25 2014
    Hyperion Therapeutics to Present at the Leerink Rare Disease Roundtable Sep 24 2014
    Salix Pharmaceuticals (SLXP) in Focus: Stock Up 5.8% Sep 24 2014
    Radius Health (RDUS) in Focus: Stock Surges 17.3% Sep 24 2014
    Hyperion Therapeutics to Host Analyst Day September 30, 2014 Sep 23 2014
    Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Sep 19 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial